Shifali, S.; Marina, D.; Zhang, D.; Tam, N.Y.; Pratheesh, M.; O’Connor, C.C.; Tumber, A.; Leung, I.K.H.; Ng, Y.M.; Leissing, T.M.; Sagheer, A.H.E.; Brown, T.; Salah, E.; Aik, W.S.; McDonough, M.A.; Schofield, C.J.
(Journal of medicinal chemistry, 2025)
FTO catalyzes the Fe(II) and 2-oxoglutarate
(2OG)-dependent modification of nucleic acids, including the
demethylation of N6-methyladenosine (m6A) in mRNA. FTO is a
proposed target for anti-cancer therapy. Using information ...